Literature DB >> 1335167

Cloning of a delta opioid receptor by functional expression.

C J Evans1, D E Keith, H Morrison, K Magendzo, R H Edwards.   

Abstract

Opiate drugs have potent analgesic and addictive properties. These drugs interact with receptors that also mediate the response to endogenous opioid peptide ligands. However, the receptors for opioids have eluded definitive molecular characterization. By transient expression in COS cells and screening with an iodinated analog of the opioid peptide enkephalin, a complementary DNA clone encoding a functional delta opioid receptor has been identified. The sequence shows homology to G protein-coupled receptors, in particular the receptors for somatostatin, angiotensin, and interleukin-8.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335167     DOI: 10.1126/science.1335167

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  191 in total

1.  Recycling and resensitization of delta opioid receptors.

Authors:  N Trapaidze; I Gomes; M Bansinath; L A Devi
Journal:  DNA Cell Biol       Date:  2000-04       Impact factor: 3.311

2.  Molecular modeling study of the differential ligand-receptor interaction at the mu, delta and kappa opioid receptors.

Authors:  M Filizola; M Carteni-Farina; J J Perez
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

3.  Differentiation of delta, mu, and kappa opioid receptor agonists based on pharmacophore development and computed physicochemical properties.

Authors:  M Filizola; H O Villar; G H Loew
Journal:  J Comput Aided Mol Des       Date:  2001-04       Impact factor: 3.686

4.  Hierarchical phosphorylation of delta-opioid receptor regulates agonist-induced receptor desensitization and internalization.

Authors:  O M Kouhen; G Wang; J Solberg; L J Erickson; P Y Law; H H Loh
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 5.  Detection and function of opioid receptors on cells from the immune system.

Authors:  J M Bidlack
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

6.  Opioid receptors from a lower vertebrate (Catostomus commersoni): sequence, pharmacology, coupling to a G-protein-gated inward-rectifying potassium channel (GIRK1), and evolution.

Authors:  M G Darlison; F R Greten; R J Harvey; H J Kreienkamp; T Stühmer; H Zwiers; K Lederis; D Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

7.  G-protein coupling of mu-opioid receptors (OP3): elevated basal signalling activity.

Authors:  N T Burford; D Wang; W Sadée
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

8.  Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic).

Authors:  Chad M Kormos; Pauline W Ondachi; Scott P Runyon; James B Thomas; S Wayne Mascarella; Ann M Decker; Hernán A Navarro; Timothy R Fennell; Rodney W Snyder; F Ivy Carroll
Journal:  J Med Chem       Date:  2018-08-29       Impact factor: 7.446

9.  Bioinformatic analysis of the human mu opioid receptor (OPRM1) splice and polymorphic variants.

Authors:  Lili Xin; Zaijie Jim Wang
Journal:  AAPS PharmSci       Date:  2002

Review 10.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.